| Year |
Citation |
Score |
| 2023 |
Meza R, Cao P, Jeon J, Warner KE, Levy DT. Trends in US Adult Smoking Prevalence, 2011 to 2022. Jama Health Forum. 4: e234213. PMID 38038988 DOI: 10.1001/jamahealthforum.2023.4213 |
0.611 |
|
| 2023 |
Sánchez-Romero LM, Liber AC, Li Y, Yuan Z, Tam J, Travis N, Jeon J, Issabakhsh M, Meza R, Levy DT. The smoking and vaping model, A user-friendly model for examining the country-specific impact of nicotine VAPING product use: application to Germany. Bmc Public Health. 23: 2299. PMID 37990171 DOI: 10.1186/s12889-023-17152-y |
0.558 |
|
| 2023 |
Skolnick S, Cao P, Jeon J, Meza R. Contribution of smoking, disease history, and survival to lung cancer disparities in Black individuals. Journal of the National Cancer Institute. Monographs. 2023: 204-211. PMID 37947334 DOI: 10.1093/jncimonographs/lgad016 |
0.623 |
|
| 2023 |
Meza R, Cao P, de Nijs K, Jeon J, Smith RA, Ten Haaf K, de Koning H. Assessing the impact of increasing lung screening eligibility by relaxing the maximum years-since-quit threshold. A simulation modeling study. Cancer. PMID 37909874 DOI: 10.1002/cncr.34925 |
0.604 |
|
| 2023 |
Brouwer AF, Jeon J, Jimenez-Mendoza E, Land SR, Holford TR, Friedman AS, Tam J, Mistry R, Levy DT, Meza R. Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of adults in the PATH Study in 2017-2019 vs 2019-2021. Medrxiv : the Preprint Server For Health Sciences. PMID 37905028 DOI: 10.1101/2023.10.20.23297320 |
0.518 |
|
| 2023 |
Hong YR, Wheeler M, Wang R, Karanth S, Yoon HS, Meza R, Kaye F, Bian J, Jeon J, Gould MK, Braithwaite D. Patient-Provider Discussion About Lung Cancer Screening by Race and Ethnicity: Implications for Equitable Uptake of Lung Cancer Screening. Clinical Lung Cancer. PMID 37673782 DOI: 10.1016/j.cllc.2023.08.013 |
0.551 |
|
| 2023 |
Jeon J, Mok Y, Meza R. Cross-sectional Patterns and Longitudinal Transitions of Premium and Non-Premium Cigar Use in the United States. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 25: S16-S23. PMID 37506231 DOI: 10.1093/ntr/ntad031 |
0.42 |
|
| 2023 |
Shafie Khorassani F, Brouwer AF, Hirschtick JL, Jeon J, Jimenez-Mendoza E, Meza R, Fleischer NL. Patterns of poly tobacco use among adults in the Population Assessment of Tobacco and Health (PATH) study, 2013-2017: a multistate Markov transition analysis. Tobacco Control. PMID 37094934 DOI: 10.1136/tc-2022-057822 |
0.513 |
|
| 2023 |
Cook S, Hirschtick JL, Barnes G, Arenberg D, Bondarenko I, Patel A, Jiminez Mendoza E, Jeon J, Levy D, Meza R, Fleischer NL. Time-varying association between cigarette and ENDS use on incident hypertension among US adults: a prospective longitudinal study. Bmj Open. 13: e062297. PMID 37085311 DOI: 10.1136/bmjopen-2022-062297 |
0.488 |
|
| 2023 |
Brouwer AF, Jeon J, Jimenez-Mendoza E, Land SR, Holford TR, Friedman AS, Tam J, Mistry R, Levy DT, Meza R. Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of youth and adults in the PATH Study in 2015-2017 vs 2017-2019. Tobacco Control. PMID 36977570 DOI: 10.1136/tc-2022-057905 |
0.488 |
|
| 2023 |
Phung MT, Pearce CL, Meza R, Jeon J. Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992-2019. Cancer Research Communications. 3: 1-8. PMID 36968229 DOI: 10.1158/2767-9764.CRC-22-0410 |
0.503 |
|
| 2023 |
Levy DT, Tam J, Jeon J, Holford TR, Fleischer NL, Meza R. Summary and Concluding Remarks: Patterns of Birth Cohort‒Specific Smoking Histories. American Journal of Preventive Medicine. 64: S72-S79. PMID 36935130 DOI: 10.1016/j.amepre.2022.12.007 |
0.615 |
|
| 2023 |
Cao P, Jeon J, Tam J, Fleischer NL, Levy DT, Holford TR, Meza R. Smoking Disparities by Level of Educational Attainment and Birth Cohort in the U.S. American Journal of Preventive Medicine. 64: S22-S31. PMID 36935129 DOI: 10.1016/j.amepre.2022.06.021 |
0.536 |
|
| 2023 |
Cook SF, Hirschtick JL, Fleischer NL, Arenberg DA, Barnes GD, Levy DT, Sanchez-Romero LM, Jeon J, Meza R. Cigarettes, ENDS Use, and Chronic Obstructive Pulmonary Disease Incidence: A Prospective Longitudinal Study. American Journal of Preventive Medicine. PMID 36890083 DOI: 10.1016/j.amepre.2023.01.038 |
0.51 |
|
| 2023 |
Tam J, Levy DT, Feuer EJ, Jeon J, Holford TR, Meza R. Using the Past to Understand the Future of U.S. and Global Smoking Disparities: A Birth Cohort Perspective. American Journal of Preventive Medicine. PMID 36781373 DOI: 10.1016/j.amepre.2022.12.003 |
0.564 |
|
| 2023 |
Tam J, Jaffri MA, Mok Y, Jeon J, Szklo AS, Souza MC, Holford TR, Levy DT, Cao P, Sánchez-Romero LM, Meza R. Patterns of Birth Cohort‒Specific Smoking Histories in Brazil. American Journal of Preventive Medicine. PMID 36775755 DOI: 10.1016/j.amepre.2022.12.002 |
0.581 |
|
| 2023 |
Jeon J, Inoue-Choi M, Mok Y, McNeel TS, Tam J, Freedman ND, Meza R. Mortality Relative Risks by Smoking, Race/Ethnicity, and Education. American Journal of Preventive Medicine. PMID 36775754 DOI: 10.1016/j.amepre.2022.12.006 |
0.549 |
|
| 2023 |
Toumazis I, Cao P, de Nijs K, Bastani M, Munshi V, Hemmati M, Ten Haaf K, Jeon J, Tammemägi M, Gazelle GS, Feuer EJ, Kong CY, Meza R, de Koning HJ, Plevritis SK, et al. Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis. Annals of Internal Medicine. PMID 36745885 DOI: 10.7326/M22-2216 |
0.557 |
|
| 2023 |
Holford TR, McKay L, Jeon J, Tam J, Cao P, Fleischer NL, Levy DT, Meza R. Smoking Histories by State in the U.S. American Journal of Preventive Medicine. PMID 36653233 DOI: 10.1016/j.amepre.2022.08.018 |
0.568 |
|
| 2023 |
Meza R, Cao P, Jeon J, Fleischer NL, Holford TR, Levy DT, Tam J. Patterns of Birth Cohort‒Specific Smoking Histories by Race and Ethnicity in the U.S. American Journal of Preventive Medicine. PMID 36653232 DOI: 10.1016/j.amepre.2022.06.022 |
0.582 |
|
| 2023 |
Jeon J, Cao P, Fleischer NL, Levy DT, Holford TR, Meza R, Tam J. Birth Cohort‒Specific Smoking Patterns by Family Income in the U.S. American Journal of Preventive Medicine. PMID 36653231 DOI: 10.1016/j.amepre.2022.07.019 |
0.564 |
|
| 2022 |
Mok Y, Jeon J, Levy DT, Meza R. Associations between e-cigarette use and e-cigarette flavors with cigarette smoking quit attempts and quit success: Evidence from a US large, nationally representative 2018-2019 survey. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 36250607 DOI: 10.1093/ntr/ntac241 |
0.556 |
|
| 2022 |
Cao P, Jeon J, Meza R. Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study. Journal of Medical Screening. 9691413221118194. PMID 35989646 DOI: 10.1177/09691413221118194 |
0.564 |
|
| 2022 |
Hirschtick JL, Cook S, Patel A, Barnes GD, Arenberg D, Bondarenko I, Levy DT, Jeon J, Jimenez Mendoza E, Meza R, Fleischer NL. Longitudinal associations between exclusive and dual use of electronic nicotine delivery systems and cigarettes and self-reported incident diagnosed cardiovascular disease among adults. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 35907264 DOI: 10.1093/ntr/ntac182 |
0.462 |
|
| 2022 |
Brouwer AF, Engle JM, Jeon J, Meza R. Sociodemographic survival disparities for lung cancer in the United States, 2000-2016. Journal of the National Cancer Institute. PMID 35866998 DOI: 10.1093/jnci/djac144 |
0.515 |
|
| 2022 |
Cao P, Smith L, Mandelblatt JS, Jeon J, Taylor KL, Zhao A, Levy DT, Williams RM, Meza R, Jayasekera J. Cost-Effectiveness of a Telephone-based Smoking Cessation Randomized Trial in the Lung Cancer Screening Setting. Jnci Cancer Spectrum. PMID 35818125 DOI: 10.1093/jncics/pkac048 |
0.604 |
|
| 2022 |
Taylor KL, Williams RM, Li T, Luta G, Smith L, Davis KM, Stanton C, Niaura R, Abrams D, Lobo T, Mandelblatt J, Jayasekera J, Meza R, Jeon J, Cao P, et al. A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting. Journal of the National Cancer Institute. PMID 35818122 DOI: 10.1093/jnci/djac127 |
0.614 |
|
| 2022 |
Meza R, Jeon J, Jimenez-Mendoza E, Mok Y, Cao P, Foley KL, Chiles C, Ostroff JS, Cinciripini PM, Minnix J, Rigotti NA, Haas JS, Taylor K, Williams RM, Toll BA, et al. National Cancer Institute Smoking Cessation at Lung Examination Trials Brief Report: Baseline Characteristics and Comparison With the U.S. General Population of Lung Cancer Screening-Eligible Patients. Jto Clinical and Research Reports. 3: 100352. PMID 35815319 DOI: 10.1016/j.jtocrr.2022.100352 |
0.644 |
|
| 2022 |
Braithwaite D, Karanth SD, Slatore CG, Zhang D, Bian J, Meza R, Jeon J, Tammemagi M, Schabath M, Wheeler M, Guo Y, Hochhegger B, Kaye FJ, Silvestri GA, Gould MK. Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study. Bmj Open. 12: e064142. PMID 35732383 DOI: 10.1136/bmjopen-2022-064142 |
0.562 |
|
| 2022 |
Meza R, Jeon J. Mechanistic and biologically based models in epidemiology; a powerful underutilized tool. American Journal of Epidemiology. PMID 35650016 DOI: 10.1093/aje/kwac099 |
0.495 |
|
| 2022 |
Brouwer AF, Levy DT, Jeon J, Jimenez-Mendoza E, Sanchez-Romero LM, Mistry R, Meza R. The impact of current tobacco product use definitions on estimates of transitions between cigarette and ENDS use. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 35589561 DOI: 10.1093/ntr/ntac132 |
0.46 |
|
| 2021 |
Tam J, Jeon J, Thrasher JF, Hammond D, Holford TR, Levy DT, Meza R. Estimated Prevalence of Smoking and Smoking-Attributable Mortality Associated With Graphic Health Warnings on Cigarette Packages in the US From 2022 to 2100. Jama Health Forum. 2: e212852. PMID 35977179 DOI: 10.1001/jamahealthforum.2021.2852 |
0.559 |
|
| 2021 |
Cook S, Hirschtick JL, Patel A, Brouwer A, Jeon J, Levy DT, Meza R, Fleischer NL. A longitudinal study of menthol cigarette use and smoking cessation among adult smokers in the US: Assessing the roles of racial disparities and E-cigarette use. Preventive Medicine. 154: 106882. PMID 34793851 DOI: 10.1016/j.ypmed.2021.106882 |
0.592 |
|
| 2021 |
Brouwer AF, Jeon J, Cook SF, Usidame B, Hirschtick JL, Jimenez-Mendoza E, Mistry R, Fleischer NL, Holford TR, Mendez D, Levy DT, Meza R. The Impact of Menthol Cigarette Flavor in the U.S.: Cigarette and ENDS Transitions by Sociodemographic Group. American Journal of Preventive Medicine. PMID 34740512 DOI: 10.1016/j.amepre.2021.08.007 |
0.563 |
|
| 2021 |
Toumazis I, de Nijs K, Cao P, Bastani M, Munshi V, Ten Haaf K, Jeon J, Gazelle GS, Feuer EJ, de Koning HJ, Meza R, Kong CY, Han SS, Plevritis SK. Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening. Jama Oncology. PMID 34673885 DOI: 10.1001/jamaoncol.2021.4942 |
0.569 |
|
| 2021 |
Meza R, Cao P, Jeon J, Taylor KL, Mandelblatt JS, Feuer EJ, Lowy DR. Brief Report: Impact of joint lung cancer screening and cessation interventions under the new USPSTF recommendations. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 34648947 DOI: 10.1016/j.jtho.2021.09.011 |
0.564 |
|
| 2021 |
Levy DT, Meza R, Yuan Z, Li Y, Cadham C, Sanchez-Romero LM, Travis N, Knoll M, Liber AC, Mistry R, Hirschtick JL, Fleischer NL, Skolnick S, Brouwer AF, Douglas C, ... Jeon J, et al. Public health impact of a US ban on menthol in cigarettes and cigars: a simulation study. Tobacco Control. PMID 34475258 DOI: 10.1136/tobaccocontrol-2021-056604 |
0.538 |
|
| 2021 |
Mistry R, Bondarenko I, Jeon J, Brouwer AF, Mattingly DT, Hirschtick JL, Jimenez-Mendoza E, Levy DT, Land SR, Elliott MR, Taylor JMG, Meza R, Fleischer NL. Latent class analysis of use frequencies for multiple tobacco products in US adults. Preventive Medicine. 106762. PMID 34358593 DOI: 10.1016/j.ypmed.2021.106762 |
0.455 |
|
| 2021 |
Sánchez-Romero LM, Cadham CJ, Hirschtick JL, Mattingly DT, Cho B, Fleischer NL, Brouwer A, Mistry R, Land SR, Jeon J, Meza R, Levy DT. A comparison of tobacco product prevalence by different frequency of use thresholds across three US surveys. Bmc Public Health. 21: 1203. PMID 34162379 DOI: 10.1186/s12889-021-11283-w |
0.48 |
|
| 2021 |
Levy DT, Sánchez-Romero LM, Travis N, Yuan Z, Li Y, Skolnick S, Jeon J, Tam J, Meza R. US Nicotine Vaping Product Simulation Model: The Effect of Vaping and Tobacco Control Policies on Smoking Prevalence and Smoking-Attributable Deaths. International Journal of Environmental Research and Public Health. 18. PMID 34063672 DOI: 10.3390/ijerph18094876 |
0.591 |
|
| 2021 |
Levy DT, Tam J, Sanchez-Romero LM, Li Y, Yuan Z, Jeon J, Meza R. Public health implications of vaping in the USA: the smoking and vaping simulation model. Population Health Metrics. 19: 19. PMID 33865410 DOI: 10.1186/s12963-021-00250-7 |
0.56 |
|
| 2021 |
Chang JT, Meza R, Levy DT, Arenberg D, Jeon J. Prediction of COPD risk accounting for time-varying smoking exposures. Plos One. 16: e0248535. PMID 33690706 DOI: 10.1371/journal.pone.0248535 |
0.564 |
|
| 2021 |
Meza R, Jeon J, Toumazis I, Ten Haaf K, Cao P, Bastani M, Han SS, Blom EF, Jonas DE, Feuer EJ, Plevritis SK, de Koning HJ, Kong CY. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force. Jama. 325: 988-997. PMID 33687469 DOI: 10.1001/jama.2021.1077 |
0.608 |
|
| 2021 |
Cadham CJ, Cao P, Jayasekera J, Taylor KL, Levy DT, Jeon J, Elkin E, Foley KL, Joseph A, Kong CY, Minnix JA, Rigotti NA, Toll BA, Zeliadt SB, Meza R, et al. Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study. Journal of the National Cancer Institute. PMID 33484569 DOI: 10.1093/jnci/djab002 |
0.624 |
|
| 2020 |
Brouwer AF, Jeon J, Hirschtick JL, Jimenez-Mendoza E, Mistry R, Bondarenko IV, Land SR, Holford TR, Levy DT, Taylor JMG, Fleischer NL, Meza R. Transitions between cigarette, ENDS and dual use in adults in the PATH study (waves 1-4): multistate transition modelling accounting for complex survey design. Tobacco Control. PMID 33199541 DOI: 10.1136/tobaccocontrol-2020-055967 |
0.469 |
|
| 2020 |
Hirschtick JL, Mattingly DT, Cho B, Arciniega LZ, Levy DT, Sanchez-Romero LM, Jeon J, Land SR, Mistry R, Meza R, Fleischer NL. Exclusive, Dual, and Polytobacco Use Among US Adults by Sociodemographic Factors: Results From 3 Nationally Representative Surveys. American Journal of Health Promotion : Ajhp. 890117120964065. PMID 33047619 DOI: 10.1177/0890117120964065 |
0.444 |
|
| 2020 |
Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R. Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. Plos Medicine. 17: e1003403. PMID 32976487 DOI: 10.1371/journal.pmed.1003403 |
0.523 |
|
| 2020 |
Cao P, Jeon J, Levy DT, Jayasekera J, Cadham C, Mandelblatt J, Taylor K, Meza R. Potential Impact of Cessation Interventions at the Point of Lung Cancer Screening on Lung Cancer and Overall Mortality in the United States. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 32160967 DOI: 10.1016/J.Jtho.2020.02.008 |
0.684 |
|
| 2020 |
Han SS, Chow E, Ten Haaf K, Toumazis I, Cao P, Bastani M, Tammemagi M, Jeon J, Feuer E, Meza R, Plevritis S. Disparities of national lung cancer screening guidelines in the U.S. population. Journal of the National Cancer Institute. PMID 32040195 DOI: 10.1093/Jnci/Djaa013 |
0.654 |
|
| 2019 |
Wang X, O'Connell K, Jeon J, Song M, Hunter D, Hoffmeister M, Lin Y, Berndt S, Brenner H, Chan AT, Chang-Claude J, Gong J, Gunter MJ, Harrison TA, Hayes RB, et al. Combined effect of modifiable and non-modifiable risk factors for colorectal cancer risk in a pooled analysis of 11 population-based studies. Bmj Open Gastroenterology. 6: e000339. PMID 31875139 DOI: 10.1136/Bmjgast-2019-000339 |
0.337 |
|
| 2019 |
Archambault AN, Su YR, Jeon J, Thomas M, Lin Y, Conti DV, Win AK, Sakoda LC, Lansdorp-Vogelaar I, Peterse EF, Zauber AG, Duggan D, Holowatyj AN, Huyghe JR, Brenner H, et al. Cumulative Burden of Colorectal Cancer-Associated Genetic Variants is More Strongly Associated With Early-onset vs Late-onset Cancer. Gastroenterology. PMID 31866242 DOI: 10.1053/J.Gastro.2019.12.012 |
0.359 |
|
| 2019 |
Criss SD, Cao P, Bastani M, Ten Haaf K, Chen Y, Sheehan DF, Blom EF, Toumazis I, Jeon J, de Koning HJ, Plevritis SK, Meza R, Kong CY. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study. Annals of Internal Medicine. PMID 31683314 DOI: 10.7326/M19-0322 |
0.597 |
|
| 2019 |
Salvatore M, Jeon J, Meza R. Changing trends in liver cancer incidence by race/ethnicity and sex in the US: 1992-2016. Cancer Causes & Control : Ccc. PMID 31606852 DOI: 10.1007/S10552-019-01237-4 |
0.543 |
|
| 2019 |
Ten Haaf K, Bastani M, Cao P, Jeon J, Toumazis I, Han SS, Plevritis SK, Blom EF, Kong CY, Tammemägi MC, Feuer EJ, Meza R, de Koning HJ. A comparative modeling analysis of risk-based lung cancer screening strategies. Journal of the National Cancer Institute. PMID 31566216 DOI: 10.1093/Jnci/Djz164 |
0.589 |
|
| 2019 |
Cadham CJ, Jayasekera JC, Advani SM, Fallon SJ, Stephens JL, Braithwaite D, Jeon J, Cao P, Levy DT, Meza R, Taylor KL, Mandelblatt JS. Smoking cessation interventions for potential use in the lung cancer screening setting: A systematic review and meta-analysis. Lung Cancer (Amsterdam, Netherlands). 135: 205-216. PMID 31446996 DOI: 10.1016/J.Lungcan.2019.06.024 |
0.652 |
|
| 2019 |
Tammemägi MC, Ten Haaf K, Toumazis I, Kong CY, Han SS, Jeon J, Commins J, Riley T, Meza R. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial. Jama Network Open. 2: e190204. PMID 30821827 DOI: 10.1001/jamanetworkopen.2019.0204 |
0.536 |
|
| 2019 |
Jeon J, Cao P, Luan D, Tam J, Levy D, Fleischer N, Holford T, Meza R. OA09.03 Patterns of Birth Cohort-Specific Smoking Histories by Family Income in the USA, 1982-2017 Journal of Thoracic Oncology. 14: S229. DOI: 10.1016/J.Jtho.2019.08.455 |
0.585 |
|
| 2019 |
Han S, Chow E, Haaf KT, Toumazis I, Bastani M, Tammemägi M, Jeon J, Feuer E, Meza R, Plevritis S. P1.11-03 Disparities and National Lung Cancer Screening Guidelines in the U.S. Population Journal of Thoracic Oncology. 14: S515-S516. DOI: 10.1016/J.Jtho.2019.08.1076 |
0.588 |
|
| 2019 |
Meza R, Cao P, Jeon J, Holford T. P1.10-01 Patterns of Birth Cohort-Specific Smoking Histories by Race and Ethnicity in the US, 1965-2017 Journal of Thoracic Oncology. 14: S509-S510. DOI: 10.1016/J.Jtho.2019.08.1063 |
0.601 |
|
| 2018 |
Jeon J, Holford TR, Levy DT, Feuer EJ, Cao P, Tam J, Clarke L, Clarke J, Kong CY, Meza R. Smoking and Lung Cancer Mortality in the United States From 2015 to 2065: A Comparative Modeling Approach. Annals of Internal Medicine. PMID 30304504 DOI: 10.7326/M18-1250 |
0.675 |
|
| 2018 |
Chang JT, Jeon J, Sriplung H, Yeesoonsang S, Bilheem S, Rozek L, Chitapanarux I, Pongnikorn D, Daoprasert K, Vatanasapt P, Suwanrungruang K, Meza R. Temporal Trends and Geographic Patterns of Lung Cancer Incidence by Histology in Thailand, 1990 to 2014. Journal of Global Oncology. 1-29. PMID 30192698 DOI: 10.1200/Jgo.18.00013 |
0.586 |
|
| 2018 |
Tam J, Levy DT, Jeon J, Clarke J, Gilkeson S, Hall T, Feuer EJ, Holford TR, Meza R. Projecting the effects of tobacco control policies in the USA through microsimulation: a study protocol. Bmj Open. 8: e019169. PMID 29574440 DOI: 10.1136/Bmjopen-2017-019169 |
0.587 |
|
| 2018 |
Jeon J, Du M, Schoen RE, Hoffmeister M, Newcomb PA, Berndt SI, Caan B, Campbell PT, Chan AT, Chang-Claude J, Giles GG, Gong J, Harrison TA, Huyghe JR, Jacobs EJ, et al. Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology. PMID 29458155 DOI: 10.1053/J.Gastro.2018.02.021 |
0.36 |
|
| 2018 |
Lau YK, Cao P, Jeon J, Meza R. Age, period and cohort trends in smoking in Mexico, 2000-2016 Tobacco Induced Diseases. 16. DOI: 10.18332/Tid/84285 |
0.618 |
|
| 2018 |
Cao P, Jeon J, Tam J, Holford TR, Fleischer NL, Meza R. Smoking disparities by level of educational attainment in the United States, 1966 to 2015 Tobacco Induced Diseases. 16. DOI: 10.18332/Tid/84014 |
0.565 |
|
| 2018 |
Jeon J, Meza R, Rozek L, Sriplung H. Trends of Colorectal Cancer Incidence in Thailand by Age, Gender, and Region Journal of Global Oncology. 4: 11s-11s. DOI: 10.1200/Jgo.18.73800 |
0.536 |
|
| 2018 |
Jeon J, Holford T, Levy D, Feuer E, Cao P, Tam J, Clarke L, Clarke J, Kong C, Meza R. OA09.05 Potential Reduction in Lung Cancer Mortality in the US from 2015-2065: A Comparative Modeling Approach Journal of Thoracic Oncology. 13: S341-S342. DOI: 10.1016/J.Jtho.2018.08.284 |
0.576 |
|
| 2017 |
Han SS, Ten Haaf K, Hazelton WD, Jeon J, Meza R, Kong CY, Feuer EJ, de Koning HJ, Plevritis SK. Re: Think Before You Leap. International Journal of Cancer. PMID 29194597 DOI: 10.1002/Ijc.31183 |
0.447 |
|
| 2017 |
Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. Plos Medicine. 14: e1002277. PMID 28376113 DOI: 10.1371/Journal.Pmed.1002277 |
0.692 |
|
| 2017 |
Han SS, Ten Haaf K, Hazelton WD, Munshi VN, Jeon J, Erdogan SA, Johanson C, McMahon PM, Meza R, Kong CY, Feuer EJ, de Koning HJ, Plevritis SK. The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. International Journal of Cancer. PMID 28073150 DOI: 10.1002/Ijc.30602 |
0.595 |
|
| 2017 |
Jeon J, Berndt SI, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Du M, Giles G, Gong J, Gruber SB, Harrison TA, Hoffmeister M, LeMarchand L, Li L, Potter JD, et al. Abstract PR17: Comprehensive colorectal cancer risk prediction to inform personalized screening and intervention Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-Pr17 |
0.379 |
|
| 2016 |
Jeon J, Berndt SI, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Du M, Giles G, Gong J, Gruber SB, Harrison TA, Hoffmeister M, LeMarchand L, Li L, Potter JD, et al. Abstract 2587: Comprehensive colorectal cancer risk prediction to inform personalized screening and intervention Cancer Research. 76: 2587-2587. DOI: 10.1158/1538-7445.Am2016-2587 |
0.389 |
|
| 2015 |
Lemire M, Qu C, Loo LW, Zaidi SH, Wang H, Berndt SI, Bézieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Du M, Edlund CK, Gallinger S, Haile RW, ... ... Jeon J, et al. A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1. Human Genetics. PMID 26404086 DOI: 10.1007/S00439-015-1598-6 |
0.308 |
|
| 2015 |
Curtius K, Hazelton WD, Jeon J, Luebeck EG. A Multiscale Model Evaluates Screening for Neoplasia in Barrett's Esophagus. Plos Computational Biology. 11: e1004272. PMID 26001209 DOI: 10.1371/Journal.Pcbi.1004272 |
0.358 |
|
| 2015 |
Meza R, Meernik C, Jeon J, Cote ML. Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010. Plos One. 10: e0121323. PMID 25822850 DOI: 10.1371/Journal.Pone.0121323 |
0.569 |
|
| 2015 |
Jeon J, Meza R, Hazelton WD, Renehan AG, Luebeck EG. Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven analysis. Cancer Causes & Control : Ccc. 26: 859-70. PMID 25783458 DOI: 10.1007/S10552-015-0559-7 |
0.571 |
|
| 2015 |
Hsu L, Jeon J, Brenner H, Gruber SB, Schoen RE, Berndt SI, Chan AT, Chang-Claude J, Du M, Gong J, Harrison TA, Hayes RB, Hoffmeister M, Hutter CM, Lin Y, et al. A model to determine colorectal cancer risk using common genetic susceptibility Loci. Gastroenterology. 148: 1330-1339.e14. PMID 25683114 DOI: 10.1053/J.Gastro.2015.02.010 |
0.364 |
|
| 2014 |
McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, et al. Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling. Plos One. 9: e99978. PMID 24979231 DOI: 10.1371/Journal.Pone.0099978 |
0.731 |
|
| 2014 |
Kong CY, Kroep S, Curtius K, Hazelton WD, Jeon J, Meza R, Heberle CR, Miller MC, Choi SE, Lansdorp-Vogelaar I, van Ballegooijen M, Feuer EJ, Inadomi JM, Hur C, Luebeck EG. Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 997-1006. PMID 24692500 DOI: 10.1158/1055-9965.Epi-13-1233 |
0.505 |
|
| 2014 |
Meza R, ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V, van Rosmalen J, Pinsky P, McMahon PM, de Koning HJ, Feuer EJ, et al. Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials. Cancer. 120: 1713-24. PMID 24577803 DOI: 10.1002/Cncr.28623 |
0.62 |
|
| 2014 |
Holford TR, Levy DT, McKay LA, Clarke L, Racine B, Meza R, Land S, Jeon J, Feuer EJ. Patterns of birth cohort-specific smoking histories, 1965-2009. American Journal of Preventive Medicine. 46: e31-7. PMID 24439359 DOI: 10.1016/J.Amepre.2013.10.022 |
0.647 |
|
| 2014 |
Holford TR, Meza R, Warner KE, Meernik C, Jeon J, Moolgavkar SH, Levy DT. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. Jama. 311: 164-71. PMID 24399555 DOI: 10.1016/J.Jvs.2014.02.030 |
0.72 |
|
| 2014 |
de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 160: 311-20. PMID 24379002 DOI: 10.7326/M13-2316 |
0.666 |
|
| 2014 |
Hsu L, Jeon J, Brenner H, Berndt S, Chan AT, Chang-Claude J, Gruber SB, Harrison T, Hoffmeister M, Newcomb P, Potter J, Schumacher F, Slattery M, Thomas D, White E, et al. Abstract 2921: Assessing colorectal cancer risk using known genetic susceptibility variants and family history accounting for endoscopy Cancer Research. 74: 2921-2921. DOI: 10.1158/1538-7445.Am2014-2921 |
0.362 |
|
| 2013 |
Luebeck EG, Curtius K, Jeon J, Hazelton WD. Impact of tumor progression on cancer incidence curves. Cancer Research. 73: 1086-96. PMID 23054397 DOI: 10.1158/0008-5472.Can-12-2198 |
0.34 |
|
| 2012 |
Hazelton WD, Jeon J, Meza R, Moolgavkar SH. Chapter 8: The FHCRC lung cancer model. Risk Analysis : An Official Publication of the Society For Risk Analysis. 32: S99-S116. PMID 22882896 DOI: 10.1111/J.1539-6924.2011.01681.X |
0.753 |
|
| 2012 |
McCarthy WJ, Meza R, Jeon J, Moolgavkar SH. Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models. Risk Analysis : An Official Publication of the Society For Risk Analysis. 32: S69-84. PMID 22882894 DOI: 10.1111/J.1539-6924.2012.01768.X |
0.757 |
|
| 2012 |
Jeon J, Meza R, Krapcho M, Clarke LD, Byrne J, Levy DT. Chapter 5: Actual and counterfactual smoking prevalence rates in the U.S. population via microsimulation. Risk Analysis : An Official Publication of the Society For Risk Analysis. 32: S51-68. PMID 22882892 DOI: 10.1111/J.1539-6924.2011.01775.X |
0.665 |
|
| 2012 |
Moolgavkar SH, Holford TR, Levy DT, Kong CY, Foy M, Clarke L, Jeon J, Hazelton WD, Meza R, Schultz F, McCarthy W, Boer R, Gorlova O, Gazelle GS, Kimmel M, et al. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. Journal of the National Cancer Institute. 104: 541-8. PMID 22423009 DOI: 10.1093/Jnci/Djs136 |
0.757 |
|
| 2011 |
Dewanji A, Jeon J, Meza R, Luebeck EG. Number and size distribution of colorectal adenomas under the multistage clonal expansion model of cancer. Plos Computational Biology. 7: e1002213. PMID 22022253 DOI: 10.1371/Journal.Pcbi.1002213 |
0.551 |
|
| 2010 |
Meza R, Jeon J, Renehan AG, Luebeck EG. Colorectal cancer incidence trends in the United States and United kingdom: evidence of right- to left-sided biological gradients with implications for screening. Cancer Research. 70: 5419-29. PMID 20530677 DOI: 10.1158/0008-5472.Can-09-4417 |
0.543 |
|
| 2010 |
Meza R, Jeon J, Moolgavkar SH. Quantitative Cancer Risk Assessment of Nongenotoxic Carcinogens Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk Quantification. 636-658. DOI: 10.1002/9780470622728.ch25 |
0.637 |
|
| 2008 |
Meza R, Jeon J, Moolgavkar SH, Luebeck EG. Age-specific incidence of cancer: Phases, transitions, and biological implications. Proceedings of the National Academy of Sciences of the United States of America. 105: 16284-9. PMID 18936480 DOI: 10.1073/Pnas.0801151105 |
0.632 |
|
| 2008 |
Jeon J, Meza R, Moolgavkar SH, Luebeck EG. Evaluation of screening strategies for pre-malignant lesions using a biomathematical approach. Mathematical Biosciences. 213: 56-70. PMID 18374369 DOI: 10.1016/J.Mbs.2008.02.006 |
0.657 |
|
| 2006 |
Jeon J, Luebeck EG, Moolgavkar SH. Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States). Cancer Causes & Control : Ccc. 17: 971-81. PMID 16841264 DOI: 10.1007/s10552-006-0037-3 |
0.532 |
|
| Show low-probability matches. |